Corbus Pharmaceuticals Holdings Stock Forecast

Buy candidate since Aug 05, 2026

The Corbus Pharmaceuticals Holdings stock price gained 1.81% on the last trading day (Wednesday, 5th Aug 2026), rising from $9.40 to $9.57. During the last trading day the stock fluctuated 4.03% from a day low at $9.44 to a day high of $9.82. The price has been going up and down for this period, and there has been a 8.26% gain for the last 2 weeks. Volume fell on the last day by -31 thousand shares and in total, 234 thousand shares were bought and sold for approximately $2.24 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.89% during the next 3 months and, with a 90% probability hold a price between $6.04 and $10.16 at the end of this 3-month period.

CRBP Signals & Forecast

The Corbus Pharmaceuticals Holdings stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.13 and $8.95. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 29.67%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Corbus Pharmaceuticals Holdings stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.74 and $7.91. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Corbus Pharmaceuticals Holdings finds support just below today's level at $8.74. If this is broken, then the next support from accumulated volume will be at $7.91 and $7.82.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.380 between high and low, or 4.03%. For the last week, the stock has had daily average volatility of 5.21%.

Our recommended stop-loss: $9.27 (-3.18%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 43 days ago.)

Trading Expectations (CRBP) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect Corbus Pharmaceuticals Holdings to open at $9.61, and during the day (based on 14 day Average True Range), to move between $9.33 and $9.81, which gives a possible trading interval of +/-$0.485 (+/-5.20%) up or down from last closing price. If Corbus Pharmaceuticals Holdings takes out the full calculated possible swing range there will be an estimated 5.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.74 (8.67%) than the resistance at $10.92 (14.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Corbus Pharmaceuticals Holdings stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.721 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $9.61 ( 0.418%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk